Ausgabe 05 · Volume 112 · November 2014
DOI: 10.1055/s-007-35320
Editorial
781
Husted, Steen;
de Caterina, Raffaele;
Andreotti, Felicita;
Arnesen, Harald;
Bachmann, Fedor;
Huber, Kurt;
Jespersen, Jørgen;
Kristensen, Steen Dalby;
Lip, Gregory Y. H.;
Morais, Joao;
Rasmussen, Lars H.;
Siegbahn, Agneta;
Storey, Robert F.;
Weitz, Jeffrey I.;
the ESC Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease;
on behalf of:
Le Heuzey, Jean-Yves;
Ammentorp, Bettina;
Darius, Harald;
De Caterina, Raffaele;
Schilling, Richard John;
Schmitt, Josef;
Zamorano, José Luis;
Kirchhof, Paulus:
Nisar, Shaista P.;
Lordkipanidzé, Marie;
Jones, Matthew L.;
Dawood, Ban B.;
Murden, Sherina;
Cunningham, Margaret R.;
Mumford, Andrew D.;
Wilde, Jonathan T.;
Watson, Steve P.;
Mundell, Stuart J.;
Lowe, Gillian C.;
the UK GAPP Study Group;
on behalf of:
Schouten, Marcel;
Daan de Boer, J.;
Kager, Liesbeth M.;
Roelofs, Joris J. T. H.;
Meijers, Joost C. M.;
Esmon, Charles T.;
Levi, Marcel;
van ’t Veer, Cornelis;
van der Poll, Tom: